Director – Regulatory Affairs
Kiniksa Pharmaceuticals
Director – Regulatory Affairs
Kiniksa Pharmaceuticals
Biopharmaceutical therapies for debilitating diseases
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immunology and inflammation, Kiniksa is advancing a growing portfolio of approved and investigational medicines, anchored by its lead product, ARCALYST®, the first and only FDA‑approved therapy for recurrent pericarditis. Grounded in rigorous science and bold innovation, the company fosters a highly collaborative, patient‑first culture led by accomplished life sciences leaders. At Kiniksa, talented individuals are trusted and empowered to make a real impact—shaping the future of medicine while improving the lives of patients who need it most.
The Director, Regulatory Affairs develops and implements regulatory strategies and related leadership for assigned drug development and commercial projects. This role drives US and/or outside-US (OUS) regulatory submissions and health authority interactions and develops strategies to reduce risk and identify opportunities to accelerate development in line with corporate objectives and timelines. The Director combines strategic leadership with hands-on management, planning and coordination across early- and late-stage development and collaborates with internal and external stakeholders to execute program objectives in compliance with applicable regulations. The Director Regulatory affairs reports to the Executive Director, Regulatory Affairs and Writing. The Director provides Swiss-based input and direction to pipeline development, regulatory approval, and the maintenance of approvals and ongoing commercialization from a regulatory perspective.
This role is based in Zug, Switzerland and requires employees to be onsite five days per week.
Responsibilities (including, but not limited to):
Standout Skills for Impact:
Qualifications and Experience:
Compensation decisions are based on objective criteria including role responsibilities, experience/qualifications, internal equity, geographic location, and external market benchmarks.
Kiniksa is an Equal Opportunity employer and will consider you without regard to your race, color, religion, sex, sexual orientation, gender identity, transgender status, age, genetics, national origin, protected veteran status, or disability status, or any other legally protected category. We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.
Kiniksa does not accept unsolicited resumes from staffing agencies or search firms. Any resumes submitted without a signed agreement will be considered property of Kiniksa, and no fees will be paid.
Pay Range 210800 - 231000 CHF
Biopharmaceutical therapies for debilitating diseases
Kiniksa Pharmaceuticals develops and delivers therapies for patients with serious diseases that have few good treatment options. The company focuses on research and development, conducts clinical trials, and then brings approved therapies to market. Its products are created through an R&D process and are intended to be used by patients via the healthcare system, with outcomes measured to help save or improve lives. What sets Kiniksa apart is its patient-centric approach and commitment to urgency and integrity, along with a business model that combines internal R&D with partnerships and licensing to bring therapies to patients. The company aims to improve patient outcomes and quality of life by delivering effective treatments where options are limited.
Explore more opportunities at Kiniksa Pharmaceuticals